The Leukaemia Foundation is working in partnership with HSANZ to co-fund PhD scholarships.
These prestigious doctoral scholarships are awarded to Australian applicants who demonstrate outstanding merit in blood cancer research. They are open to all areas of Australian research in blood cancers and blood cancer related disorders.
Applicants’ work must align with a least one of the Leukaemia Foundation’s seven research priorities:
1. Understanding the biology of blood cancers.
2. Precision medicine – investing in new, tailor-made therapies to treat each patient’s cancer.
3. New diagnostics.
4. Novel (new) therapies.
5. Psychosocial aspects of cancer.
6. Innovative clinical trials and/or incorporation of real world data.
7. Prevention research including investigating risk factors and possible causes of blood cancers.
The PhD scholarship program offers applicants – early career scientists, nurses and haematologists – a three-year scholarship with annual funding of $40,000 (a total of $120,000 per scholarship).
The selection criteria used is based on National Health and Medical Research Council scoring.
Applications for PhD scholarships starting in January 2021 are expected to open in July 2020.